What is neurogenic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Neurogenic Shock: Definition and Pathophysiology

Neurogenic shock is a distributive form of circulatory shock caused by loss of sympathetic nervous system control following spinal cord injury (SCI), resulting in profound hypotension and bradycardia due to unopposed parasympathetic (vagal) activity. 1, 2

Core Pathophysiologic Mechanism

Neurogenic shock occurs when traumatic spinal cord injury disrupts descending sympathetic pathways from central control centers to spinal sympathetic neurons in the intermediolateral nuclei of T1-L2 cord segments. 1, 2 This disruption produces:

  • Loss of supraspinal control over the sympathetic nervous system below the injury level 1, 2
  • Reduced overall sympathetic activity below the lesion 1, 2
  • Unopposed parasympathetic outflow through the intact vagal nerve 1, 2

The result is a characteristic hemodynamic profile distinct from other shock states, though the specific mechanisms can vary between patients 3.

Clinical Presentation

Hemodynamic Criteria

Neurogenic shock manifests as severe arterial hypotension (systolic BP < 90 mmHg) combined with bradycardia—a combination that distinguishes it from hypovolemic shock, which typically presents with tachycardia. 1, 2, 4

The hemodynamic disturbance results from multiple mechanisms 3:

  • Decreased peripheral vascular resistance (33% of cases) 3
  • Loss of vascular capacitance (22% of cases) 3
  • Mixed peripheral resistance and capacitance abnormalities (33% of cases) 3
  • Purely cardiac mechanisms (11% of cases) 3

Temporal Context: Spinal Shock vs. Neurogenic Shock

Neurogenic shock is a component of the broader syndrome of spinal shock, which occurs during the acute phase following SCI and represents a transitory suspension of function and reflexes below the injury level. 1, 2 Spinal shock encompasses both neurologic and hemodynamic manifestations, whereas neurogenic shock specifically refers to the cardiovascular instability (severe hypotension and bradycardia) 1, 2.

Injury Level and Risk

Neurogenic shock predominantly occurs with cervical or high thoracic spinal cord injuries, particularly those above T5-T6 (the splanchnic sympathetic outflow level). 1, 2 The reported incidence varies significantly depending on diagnostic criteria used, with one rigorous study finding a 29% incidence in cervical SCI when appropriate hemodynamic and laboratory criteria were applied 5.

Clinical Course and Natural History

Blood pressure characteristically declines further during the first week post-injury, and current fluid management strategies often maintain patients at net zero or negative fluid balance. 5 This finding highlights that hypovolemia is frequently a confounding factor in the diagnosis and management of neurogenic shock 5.

Critical Distinguishing Features from Other Shock Types

Unlike cardiogenic shock (which shows elevated filling pressures and systemic vascular resistance) 6, 7 or hypovolemic shock (which presents with tachycardia and low filling pressures) 6, 7, neurogenic shock is characterized by:

  • Low systemic vascular resistance 6, 3
  • Bradycardia rather than tachycardia 1, 2, 4
  • Hypotension despite adequate or even excessive fluid resuscitation 5, 4
  • Loss of sympathetic tone below the injury level 1, 2

Clinical Significance and Complications

Neurogenic shock is life-threatening and aggravates the underlying neurological deficit by compromising spinal cord perfusion. 4 Cardiovascular disturbances represent the leading causes of morbidity and mortality in both acute and chronic stages of SCI 1, 2.

Additional cardiovascular complications include 1:

  • Orthostatic hypotension (both acute and chronic phases) 1
  • Deep vein thrombosis 1
  • Long-term increased risk for coronary heart disease and systemic atherosclerosis 1
  • Cardiac dysrhythmias, including rare cardiac arrest 2

Diagnostic Pitfalls

The reported incidence of neurogenic shock varies dramatically (from very low to very high) depending on which clinical definition is applied, with hypovolemia being the primary confounding factor responsible for inconsistent incidence reports between studies. 5 Accurate diagnosis requires combining hemodynamic criteria (hypotension with bradycardia) with laboratory markers and exclusion of hypovolemia 5.

References

Research

Vascular dysfunctions following spinal cord injury.

Journal of medicine and life, 2010

Research

Cardiac dysfunctions following spinal cord injury.

Journal of medicine and life, 2009

Research

[Traumatic neurogenic shock].

Annales francaises d'anesthesie et de reanimation, 2013

Guideline

Hemodynamic Differentiation of Shock Types

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Criteria for Cardiogenic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is neurogenic shock and how is it diagnosed in a patient with a suspected spinal cord injury above the level of T6 (thoracic 6)?
What are the symptoms and management of neurogenic shock?
What are the effects of neurogenic shock?
What is the best method to diagnose neurogenic (nerve-originated) shock?
What is the initial management of neurogenic shock?
When should blood work be rechecked after an intravenous iron infusion for iron‑deficiency anemia in an adult?
How should I manage a draining, splitting, and bleeding intergluteal sinus in a hidradenitis suppurativa patient on weekly adalimumab (Simlandi) who is currently using normal saline irrigation, clindamycin 1% topical, vaseline and wound patch, with collagen and extra vaseline ineffective?
How can I adjust the medication regimen of an elderly male hospice patient with chronic sequelae of a prior cerebrovascular accident, marked anxiety, poor impulse control, frequent fidgeting, and a history of falling from his chair—currently on risperidone 1 mg BID and 0.5 mg daily plus trazodone, melatonin, hydroxyzine, gabapentin, sertraline, memantine, and other agents—to reduce sedation and fall risk while improving his impulse control and anxiety?
In a tube‑fed patient with antibiotic‑induced gastroparesis and nausea who is already receiving ondansetron, should I use metoclopramide rather than diphenhydramine as the rescue anti‑emetic?
What is the appropriate starting dose of low‑dose doxepin for an adult patient with PTSD, generalized anxiety disorder, depression, and ADHD who has insomnia?
Is midazolam an opioid?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.